Health Condition 1: null- Diabetes Mellitus cases with cutaneous manifestations
Conditions
Interventions
None listed
Sponsors
Ruchi Shah
Eligibility
Inclusion criteria
Inclusion criteria: • All type-II Diabetes Mellitus cases patients attending the Diabetic clinic conducted in O.P.D. 18 ,every Wednesday and daily Medicine (O.P.D.18) and Skin and V.D. O.P.D. having one or more of the following cutaneous manifestations: Vascular Damage: - Leg ulceration - Wet gangrene of the foot - Erysipelas like erythema - Diabetic dermopathy - Rubeosis Neurological Damage: - Diabetic foot - Diabetic foot ulcer Infections Obesity and hyperlipidemia related skin disease: - Acanthosis nigricans - Skin tags - Eruptive Xanthomas of the skin Treatment related Skin manifestations: - Insulin lipodystrophy - Allergic reactions to Insulin - Allergic reactions to oral hypoglycemic drugs Disease associations and genetic syndromes: - Reactive perforating collagenosis(Folliculitis) - Autoimmune disease - Genetic and other systemic disease Miscellaneous: - Granulomatous disorders(Necrobiosis Lipoidica) - Stiff skin and joints: Cheiroarthropathy Finger pebbles Sceleredema diabeticorum - Pruritus - Diabetic Bullae
Exclusion criteria
Exclusion criteria: • Other dermatologic diseases having relation with Metabolic syndrome like Psoriasis • Cases having Autoimmune diseases like Systemic Lupus Erythematosus, cleroderma, Systemic Sclerosis which can give rise to abnormal capillaroscopic findings. • Smoking • Cases with known liver disease or other multi-system disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| â?¢To study the cutaneous manifestations of Diabetes mellitus â?¢To demonstrate nailfold capillaroscopy changes due to diabetic microangiopathy â?¢To study the correlation between cutaneous and systemic manifestations of Diabetic microangiopathy in terms of Retinopathy and nephropathy Timepoint: patients will be assessed at the time of enrollment in the study only. | — |
Secondary
| Measure | Time frame |
|---|---|
| To study the correlation between cutaneous and systemic manifestations of Diabetic microangiopathy in terms of Retinopathy and nephropathyTimepoint: patients can be followed up every 6 months for new manifestations and ophthalmic checkup | — |
Countries
India
Contacts
Public ContactRuchi Shah
Medical College,Baroda
Outcome results
None listed